Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CGB1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CCT4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PROZ | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PDLIM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SRRM4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.01 |
mRNA | CASZ1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SQRDL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | DACT3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | ZCCHC14 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | ING5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |